OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer
Weilong Ye, Zhengguo Wu, Pengbo Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Weilong Ye, Zhengguo Wu, Pengbo Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Showing 13 citing articles:
2022 updates to the Rat Genome Database: a Findable, Accessible, Interoperable, and Reusable (FAIR) resource
Mahima Vedi, Jennifer R. Smith, G. Thomas Hayman, et al.
Genetics (2023) Vol. 224, Iss. 1
Closed Access | Times Cited: 49
Mahima Vedi, Jennifer R. Smith, G. Thomas Hayman, et al.
Genetics (2023) Vol. 224, Iss. 1
Closed Access | Times Cited: 49
LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer
Yifan Liu, Yukun Han, Yanhua Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Yifan Liu, Yukun Han, Yanhua Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer
Zhuolong Xiong, Zenglei Han, Weiyi Pan, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0286122-e0286122
Open Access | Times Cited: 12
Zhuolong Xiong, Zenglei Han, Weiyi Pan, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0286122-e0286122
Open Access | Times Cited: 12
Improved prediction of prognosis and therapy response for lung adenocarcinoma after identification of DNA-directed RNA polymerase-associated lncRNAs
Jiaao Yu, Liqiang Lan, Caixin Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 12737-12754
Closed Access | Times Cited: 7
Jiaao Yu, Liqiang Lan, Caixin Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 12737-12754
Closed Access | Times Cited: 7
Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
Yue Xu, Tao Tao, Yong Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Yue Xu, Tao Tao, Yong Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6
Identification of TUBB2A as a Cancer-Immunity Cycle-Related Therapeutic Target in Triple-Negative Breast Cancer
Jia Li, Jingchun Yao, Liqiang Qi
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2467-2480
Closed Access | Times Cited: 4
Jia Li, Jingchun Yao, Liqiang Qi
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2467-2480
Closed Access | Times Cited: 4
Identification and Functional Characterization of PI3K/Akt/mTOR Pathway-Related lncRNAs in Lung Adenocarcinoma: A Retrospective Study.
Jiaqi Zhong, Ying Kong, Ruming Li, et al.
PubMed (2024) Vol. 26, Iss. 1, pp. 13-27
Closed Access | Times Cited: 1
Jiaqi Zhong, Ying Kong, Ruming Li, et al.
PubMed (2024) Vol. 26, Iss. 1, pp. 13-27
Closed Access | Times Cited: 1
A ferroptosis‐related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study
Jiaxin Dong, Tao Tao, Jiaao Yu, et al.
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Jiaxin Dong, Tao Tao, Jiaao Yu, et al.
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Computational identification of long non-coding RNAs associated with graphene therapy in glioblastoma multiforme
Zhuoheng Zou, Ming Zhang, Shang Zhong Xu, et al.
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Zhuoheng Zou, Ming Zhang, Shang Zhong Xu, et al.
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Predicting pan-cancer immune-checkpoint therapy and prognosis with a chromatin-accessibility-related alternative splicing signature: a retrospective study
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
Development and application of a predictive model for survival and drug therapy based on COVID-19-related lncRNAs in non-small cell lung cancer
Ziyuan Huang, Zenglei Han, Kairong Zheng, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40629-e40629
Open Access
Ziyuan Huang, Zenglei Han, Kairong Zheng, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40629-e40629
Open Access
